Beclometasone Dipropionate Aqueous Nasal Spray, 50 micrograms per spray Malta - angličtina - Medicines Authority

beclometasone dipropionate aqueous nasal spray, 50 micrograms per spray

generics uk limited station close, potters bar, herts, en6 1tl, united kingdom - beclometasone dipropionate - nasal spray, solution - beclometasone dipropionate 50 µg - nasal preparations

BECLOMETHASONE NASAL SPRAY SUSPENSION Kanada - angličtina - Health Canada

beclomethasone nasal spray suspension

apotex inc - beclomethasone dipropionate - suspension - 50mcg - beclomethasone dipropionate 50mcg - corticosteroids

CACHDERM-N (Beclomethasone, Neomycin Sulphate & Cream Keňa - angličtina - Pharmacy and Poisons Board

cachderm-n (beclomethasone, neomycin sulphate & cream

cachet pharmaceuticals pvt. ltd. 415, shah nahar, worli, mumbai-400018. - beclomethasone dipropionate usp, neomycin… - cream - beclomethasone dipropionate… - beclometasone and antibiotics

Beclometasone Apotex 0,05 % nas. spray susp. met. pump Belgicko - angličtina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

beclometasone apotex 0,05 % nas. spray susp. met. pump

apotex sa-nv - beclometasone dipropionate 50 µg/dose - nasal spray, suspension - 0,05 % - beclometasone dipropionate 50 µg/dose - beclometasone

QNASL- beclomethasone dipropionate aerosol, metered Spojené štáty - angličtina - NLM (National Library of Medicine)

qnasl- beclomethasone dipropionate aerosol, metered

teva respiratory, llc - beclomethasone dipropionate (unii: 5b307s63b2) (beclomethasone - unii:kgz1slc28z) - beclomethasone dipropionate 80 ug - qnasl® nasal aerosol is indicated for the treatment of the nasal symptoms associated with seasonal and perennial allergic rhinitis in patients 4 years of age and older. qnasl nasal aerosol is contraindicated in patients with a history of hypersensitivity to beclomethasone dipropionate and/or any other qnasl nasal aerosol ingredients [see warnings and precautions (5.3)] . teratogenic effects : pregnancy category c there are no adequate and well-controlled clinical trials in pregnant women treated with qnasl nasal aerosol. beclomethasone dipropionate was teratogenic and embryocidal in the mouse and rabbit although these effects were not observed in rats. qnasl nasal aerosol should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. experience with oral corticosteroids since their introduction in pharmacologic, as opposed to physiologic, doses suggests that rodents are more prone to teratogenic effects from corticosteroids than humans. beclomethasone dipropionate ad

BECLOMET EASYHALER 200 mcginhalation dose Singapur - angličtina - HSA (Health Sciences Authority)

beclomet easyhaler 200 mcginhalation dose

orion pharma (sg) pte. ltd. - beclomethasone dipropionate (micronized) - powder, metered - 200mcg/metered dose - beclomethasone dipropionate (micronized) 200mcg/metered dose

QVAR 50 Izrael - angličtina - Ministry of Health

qvar 50

abic marketing ltd, israel - beclometasone dipropionate - inhaler - beclometasone dipropionate 50 mcg/dose - beclometasone - beclometasone - prophylaxis and treatment of bronchial asthma in adults and children 5 years of age and obove.

QVAR 100 Izrael - angličtina - Ministry of Health

qvar 100

teva israel ltd - beclometasone dipropionate - inhaler - beclometasone dipropionate 100 mcg/dose - beclometasone - beclometasone - prophylaxis and treatment of bronchial asthma in adults and children 5 years of age and obove.

FOSTER 1006 Izrael - angličtina - Ministry of Health

foster 1006

kamada ltd, israel - beclometasone dipropionate anhydrous; formoterol fumarate dihydrate - pressurised solution - formoterol fumarate dihydrate 6 mcg/dose; beclometasone dipropionate anhydrous 100 mcg/dose - formoterol and beclometasone - beclometasone - foster is indicated in the regular treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta2-agonist) is appropriate:- patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled rapid-acting beta2-agonist or- patients already adequately controlled on both inhaled corticosteroids and long-acting beta2-agonists.copd :symptomatic treatment of patients with severe copd (fev1 < 50% predicted normal) and a history of repeated exacerbations, who have significant symptoms despite regular therapy with long-acting bronchodilators.